Adverse Childhood Experiences Study (ACES) {Ans: large epidemiological study involving more than 17,000 individuals from the US; analyzed long-term effects of childhood and adolescent traumatic experiences on adult health risks, mental health, healthcare costs, and life expectancy}Full agonists {Ans: opioids with the highest potential of abuse are this type of drug/interaction; morphine, heroin, methadone, oxycodone, hydromorphone}Oral naltrexone (Revia) {Ans: relatively long-lasting opioid antagonist; used to treat opioid dependence for many years and used to treat alcohol dependence sine 1994; reduces both the rewarding effects of alcohol and craving for it}Buprenorphine {Ans: research found primary efficacy in clinical trials demonstrated via patient retention and elimination of illicit-opioid-positive drug tests}Acamprosate (Campral) {Ans: third drug to receive FDA approval for postwithdrawal maintenance of alcohol abstinence; mechanism of action not clearly established, but it is thought to help modulate and normalize alcohol-related changes in brain activity, thereby reducing symptoms of postacute withdrawal, such as sleep disturbances and mood, that may trigger relapse to drinking}Motivational incentives {Ans: form of behavioral therapy; uses positive reinforcement to encourage abstinence from drugs}Oral naltrexone (Revia) {Ans: most common side effects include nausea, vomiting, headache, dizziness, fatigue, nervousness, anxiety, somnolence (drowsiness)}false {Ans: